Principal Investigators

Understanding the role of cell death in health and disease

Dr. Alessandro Annibaldi

Understanding the role of cell death in health and disease, Else Kröner Forschungskolleg Cologne

Molecular Genetics of Ageing

Prof. Dr. Adam Antebi

Molecular Genetics of Ageing, Else Kröner Forschungskolleg Cologne

Translational Tumor Genetics and Immunotherapy Research Group

Dr. Sven Borchmann

Translational Tumor Genetics and Immunotherapy Research Group, Else Kröner Forschungskolleg Cologne

Dissecting functional determinants of therapy response and immune-interactions in squamous cell carcinomas

Dr. Johannes Brägelmann

Dissecting functional determinants of therapy response and immune-interactions in squamous cell carcinomas, Else Kröner Forschungskolleg Cologne

Neuronal Control of Metabolism

Prof. Dr. Jens Brüning

Neuronal Control of Metabolism, Else Kröner Forschungskolleg Cologne

Improving the understanding of immunotherapy in patients with classical Hodgkin lymphoma

Prof. Dr. Andreas Engert

Improving the understanding of immunotherapy in patients with classical Hodgkin lymphoma, Else Kröner Forschungskolleg Cologne

Employing deep genomic sequencing to reveal the biological principles of neuroblastoma

Prof. Dr. Matthias Fischer

Employing deep genomic sequencing to reveal the biological principles of neuroblastoma, Else Kröner Forschungskolleg Cologne

Experimental Imaging and Image-Guided Therapy

Prof. Dr. Holger Grüll

Experimental Imaging and Image-Guided Therapy, Else Kröner Forschungskolleg Cologne

Translational CLL research to develop new standards of clinical care

Prof. Dr. Michael Hallek

Translational CLL research to develop new standards of clinical care, Else Kröner Forschungskolleg Cologne

Dr. Grit Herter-Sprie

Preclinical multimodal immune-oncology for lung cancer treatment

Dr. Grit Herter-Sprie, Else Kröner Forschungskolleg Cologne

(Epi)Genome structural alterations predisposing to cancer development and/or drug resistance.

Dr. Robert Hänsel-Hertsch

(Epi)Genome structural alterations predisposing to cancer development and/or drug resistance., Else Kröner Forschungskolleg Cologne

Cancer genomics to understand tumor characteristics and vulnerabilities

Prof. Dr. Axel Hillmer

Cancer genomics to understand tumor characteristics and vulnerabilities, Else Kröner Forschungskolleg Cologne

Understanding the principles of protein homeostasis in cancer and aging

Prof. Dr. Thorsten Hoppe

Understanding the principles of protein homeostasis in cancer and aging, Else Kröner Forschungskolleg Cologne

Mechanisms of DNA Repair

Dr. Ron D. Jachimowicz

Mechanisms of DNA Repair, Else Kröner Forschungskolleg Cologne

Cell Death and Immunity

Prof. Dr. Hamid Kashkar

Cell Death and Immunity, Else Kröner Forschungskolleg Cologne

Functional Proteomics

Prof. Dr. Marcus Krüger

Functional Proteomics, Else Kröner Forschungskolleg Cologne

Developing high performance computing infrastructure to facilitate the genomic profiling of tumor specimens

Prof. Dr.-Ing. Ulrich Lang

Developing high performance computing infrastructure to facilitate the genomic profiling of tumor specimens, Else Kröner Forschungskolleg Cologne

Metabolic rewiring of mitochondria in cancer

Prof. Dr. Thomas Langer

Metabolic rewiring of mitochondria in cancer, Else Kröner Forschungskolleg Cologne

Statistical Physics and Quantitative Biology

Prof. Dr. Michael Lässig

 

Cell polarity and the pathogenesis of skin cancer

Prof. Dr. Carien Niessen

Cell polarity and the pathogenesis of skin cancer, Else Kröner Forschungskolleg Cologne

Aspects of genome maintenance

Dr. Stephanie Panier

Aspects of genome maintenance, Else Kröner Forschungskolleg Cologne

Using state of the art mouse models to uncover principles of cell death and cancerogenesis

Prof. Dr. Manolis Pasparakis

Using state of the art mouse models to uncover principles of cell death and cancerogenesis, Else Kröner Forschungskolleg Cologne

Developing novel computational algorithms to decipher genomic principles of malignant transformation and clonal evolution

Prof. Dr. Martin Peifer

Developing novel computational algorithms to decipher genomic principles of malignant transformation and clonal evolution, Else Kröner Forschungskolleg Cologne

The impact of different forms of programmed cell death on disease pathogenesis

Dr. Nieves Peltzer

The impact of different forms of programmed cell death on disease pathogenesis, Else Kröner Forschungskolleg Cologne

Oncological Imaging Group

PD Dr. Thorsten Persigehl

Oncological Imaging Group, Else Kröner Forschungskolleg Cologne

Employing genetically engineered mouse models as preclinical platforms

Prof. Dr. H. Christian Reinhardt

Employing genetically engineered mouse models as preclinical platforms, Else Kröner Forschungskolleg Cologne

Focusing on the molecular mechanisms of the DNA damage response

Prof. Dr. Björn Schumacher

Focusing on the molecular mechanisms of the DNA damage response, Else Kröner Forschungskolleg Cologne

Epigenetic aberrations as key drivers of malignant transformation and clonal evolution

Prof. Dr. Michal-Ruth Schweiger 

Epigenetic aberrations as key drivers of malignant transformation and clonal evolution, Else Kröner Forschungskolleg Cologne

Pharmacogenomics to reveal cancer-specific molecular vulnerabilities

Prof. Dr. Martin Sos 

Pharmacogenomics to reveal cancer-specific molecular vulnerabilities, Else Kröner Forschungskolleg Cologne

Translational genomics to understand the impact of cancer-specific somatic mutations in lung cancer evolution

Prof. Dr. Roman Thomas 

Translational genomics to understand the impact of cancer-specific somatic mutations in lung cancer evolution, Else Kröner Forschungskolleg Cologne

Immunotherapeutic approaches and their combination with anti-angiogenetic treatment

Prof. Dr. Dr. Roland Ullrich

Immunotherapeutic approaches and their combination with anti-angiogenetic treatment, Else Kröner Forschungskolleg Cologne

Cell Death and Cancer Evolution

Prof. Dr. Silvia von Karstedt

Cell Death and Cancer Evolution, Else Kröner Forschungskolleg Cologne

Understanding and therapeutically harnessing the tumor-supportive and immuno-suppressive functions of TRAIL and CD95L in SCLC

Prof. Dr. Henning Walczak

Mechanisms of mitochondrial loss of function

Prof. Dr. Rudolf J. Wiesner

Mechanisms of mitochondrial loss of function, Else Kröner Forschungskolleg Cologne

The Lung Cancer Group Cologne serves as a translational hub within the EKFS consortium

Univ.-Prof. Dr. med. Jürgen Wolf

The Lung Cancer Group Cologne serves as a translational hub within the EKFS consortium, Else Kröner Forschungskolleg Cologne

Using mouse models to understand the impact of rewired metabolism and inflammatory processes on cancer development and progression

PD Dr. F. Thomas Wunderlich 

Using mouse models to understand the impact of rewired metabolism and inflammatory processes on cancer development and progression, Else Kröner Forschungskolleg Cologne

The Gastrointestinal Cancer Group Cologne: Translational research to develop genotype tailored therapies

PD Dr. Thomas Zander 

The Gastrointestinal Cancer Group Cologne: Translational research to develop genotype tailored therapies, Else Kröner Forschungskolleg Cologne
Partners & Participants
University Hospital of Cologne University of Cologne CIO Cologne Bonn CMMC Center of Molecular Medicine Cologne CECAD Cologne Max Planck Institute for Metabolism Research Max-Planck-Institut for Biology of Aging Else Kröner Fresenius Stiftung
Contact

Else Kröner Forschungskolleg Köln
c/o University Hospital Cologne
Department of Internal Medicine
Center for Integrated Oncology (CIO ABCD)
Kerpener Str. 62, 50937, Cologne, Germany
Phone: +49-221-478-38376
Email: info@ekf-cologne.de
www.ekf-cologne.de

German language version
Imprint | Privacy Policy